SG/PUT/FRESENIUS/30/0.1/20.12.24 Stock

Warrant

DE000SQ66MC5

Delayed Deutsche Boerse AG 12:56:47 2024-06-03 EDT
0.26 EUR +4.00% Intraday chart for SG/PUT/FRESENIUS/30/0.1/20.12.24
1 month-30.56%
3 months-47.92%
Date Price Change
24-06-03 0.26 +4.00%
24-05-31 0.25 -7.41%
24-05-30 0.27 0.00%
24-05-29 0.27 +3.85%
24-05-28 0.26 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 12:56 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SQ66MC
ISINDE000SQ66MC5
Date issued 2023-01-10
Strike 30
Maturity 2024-12-20 (200 Days)
Parity 10 : 1
Emission price 0.58
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.86
Lowest since issue 0.24
Spread 0.01
Spread %3.70%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.28 EUR
Average target price
37.16 EUR
Spread / Average Target
+26.92%
Consensus